Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. (full– 2014) http://journal.frontiersin.org/Journ...014.00037/full
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014) http://www.thejournalofheadacheandpa...2377-15-14.pdf
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. (full – 2014) http://www.jbc.org/content/early/201...13.536953.long
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis. (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease. (full– 2014) http://iospress.metapress.com/conten...3%2fJAD-131961
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883962/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. (full – 2014) http://www.plosone.org/article/fetch...esentation=PDF
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective. (full– 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat. (full – 2014) http://www.hindawi.com/journals/bmri/2014/971750/
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full – 2014) http://www.hindawi.com/journals/bmri/2014/502542/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity (full – 2014) http://jhc.sagepub.com/content/62/6/395.full
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full – 2014) http://www.plosone.org/article/info%...l.pone.0099450
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Repositioning therapy for thyroid cancer: new insights on established medications. (full – 2014) http://erc.endocrinology-journals.or...21/3/R183.long
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. (link to PDF – 2014 http://life.scichina.com:8082/sciCe/...t513395.shtml#
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet. (link to PDF – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24993629
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2. (link to PDF – 2014) http://www.mdpi.com/1422-0067/15/8/13637
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24440992
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24399199
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24486541
Switching cannabinoid response from CB2 agonists to FAAH inhibitors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127
Targeting the cannabinoid system for pain relief? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529672
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24583052
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969
Intrathecal Injection of JWH015 Attenuates Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Activation of Spinal Glia in a Rat Model. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24651239
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24721671
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Synthetic marijuana "K2" induced ITP. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth. (abst – 2014) http://pubs.acs.org/doi/abs/10.1021/mp5001923
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813316
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24827776
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24831513
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
What we know and do not know about the cannabinoid receptor 2 (CB2). (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24877594
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24972960
The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980781
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24978314
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst – 2014) http://iospress.metapress.com/conten...51455c445&pi=4
Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25023974
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload. (abst – 2014) http://www.freedomwares.ca/p80cannab...sure-overload/
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signaling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25048571
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (abst – 2014) http://www.jbc.org/content/early/201...3-49611e578de4
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058046
UEA research reveals how cannabis compound could slow tumour growth (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
Synthetic cannabinoid molecule created for osteoarthritis (news – 2014) http://www.news-medical.net/news/201...arthritis.aspx
Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014) http://www.sciencedaily.com/releases...0107092825.htm
How marijuana shrinks cancerous tumours (news – 2014) https://en-maktoob.news.yahoo.com/ma...122611456.html
Protection from osteoarthritis may lie in our own joints, study suggests (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
Drugs related to cannabis have pain-relieving potential for osteoarthritis (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
CBR - CBe* (Endothelial Cannabinoid Receptor)
The quest for a vascular endothelial cannabinoid receptor. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. (full – 2003) http://molpharm.aspetjournals.org/content/63/3/699.long
The complexities of the cardiovascular actions of cannabinoids (full – 2004) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full – 2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. (full – 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616976/
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. (full – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. (full – 2014) http://download.springer.com/static/...74992&ext=.pdf
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Endothelial atypical cannabinoid receptor: do we have enough evidence? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25073723
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full – 2014) http://www.thejournalofheadacheandpa...2377-15-14.pdf
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. (full – 2014) http://www.jbc.org/content/early/201...13.536953.long
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis. (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease. (full– 2014) http://iospress.metapress.com/conten...3%2fJAD-131961
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883962/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity. (full – 2014) http://www.plosone.org/article/fetch...esentation=PDF
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective. (full– 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
The endocannabinoid system: a putative role in neurodegenerative diseases. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat. (full – 2014) http://www.hindawi.com/journals/bmri/2014/971750/
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full – 2014) http://www.hindawi.com/journals/bmri/2014/502542/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity (full – 2014) http://jhc.sagepub.com/content/62/6/395.full
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full – 2014) http://www.plosone.org/article/info%...l.pone.0099450
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Repositioning therapy for thyroid cancer: new insights on established medications. (full – 2014) http://erc.endocrinology-journals.or...21/3/R183.long
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. (link to PDF – 2014 http://life.scichina.com:8082/sciCe/...t513395.shtml#
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet. (link to PDF – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24993629
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http://www.impactjournals.com/oncota...e&op=view&path[]=2233
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2. (link to PDF – 2014) http://www.mdpi.com/1422-0067/15/8/13637
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24440992
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24399199
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24486541
Switching cannabinoid response from CB2 agonists to FAAH inhibitors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508127
Targeting the cannabinoid system for pain relief? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529672
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24583052
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969
Intrathecal Injection of JWH015 Attenuates Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Activation of Spinal Glia in a Rat Model. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24651239
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24709540
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24721671
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742657
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Synthetic marijuana "K2" induced ITP. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth. (abst – 2014) http://pubs.acs.org/doi/abs/10.1021/mp5001923
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813316
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24827776
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24831513
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
What we know and do not know about the cannabinoid receptor 2 (CB2). (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24877594
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24972960
The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980781
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24978314
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst – 2014) http://iospress.metapress.com/conten...51455c445&pi=4
Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25023974
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload. (abst – 2014) http://www.freedomwares.ca/p80cannab...sure-overload/
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signaling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25048571
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (abst – 2014) http://www.jbc.org/content/early/201...3-49611e578de4
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058046
UEA research reveals how cannabis compound could slow tumour growth (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
Synthetic cannabinoid molecule created for osteoarthritis (news – 2014) http://www.news-medical.net/news/201...arthritis.aspx
Drugs Related to Cannabis Have Pain-Relieving Potential for Osteoarthritis (news – 2014) http://www.sciencedaily.com/releases...0107092825.htm
How marijuana shrinks cancerous tumours (news – 2014) https://en-maktoob.news.yahoo.com/ma...122611456.html
Protection from osteoarthritis may lie in our own joints, study suggests (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
Drugs related to cannabis have pain-relieving potential for osteoarthritis (news – 2014) http://www.alphagalileo.org/ViewItem...CultureCode=en
CBR - CBe* (Endothelial Cannabinoid Receptor)
The quest for a vascular endothelial cannabinoid receptor. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. (full – 2003) http://molpharm.aspetjournals.org/content/63/3/699.long
The complexities of the cardiovascular actions of cannabinoids (full – 2004) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full – 2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. (full – 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616976/
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. (full – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries. (full – 2014) http://download.springer.com/static/...74992&ext=.pdf
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Endothelial atypical cannabinoid receptor: do we have enough evidence? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25073723